KRASMutation Reduces Thymoquinone Anticancer Effects on Viability of Cells and Apoptosis

MLA

Betul Yenigun, Vildan, et al. “KRASMutation Reduces Thymoquinone Anticancer Effects on Viability of Cells and Apoptosis.” Anti-Cancer Agents in Medicinal Chemistry, vol. 23, no. 15, Jan. 2024, pp. 1747–53. EBSCOhost, https://doi.org/10.2174/1871520623666230517123807.

APA

Betul Yenigun, V., Acar, H., Kanimdan, E., Yenigun, A., Kocyigit, A., & Cora, T. (2024). KRASMutation Reduces Thymoquinone Anticancer Effects on Viability of Cells and Apoptosis. Anti-Cancer Agents in Medicinal Chemistry, 23(15), 1747–1753. https://doi.org/10.2174/1871520623666230517123807

Chicago

Betul Yenigun, Vildan, Hasan Acar, Ebru Kanimdan, Alper Yenigun, Abdurrahim Kocyigit, and Tulin Cora. 2024. “KRASMutation Reduces Thymoquinone Anticancer Effects on Viability of Cells and Apoptosis.” Anti-Cancer Agents in Medicinal Chemistry 23 (15): 1747–53. doi:10.2174/1871520623666230517123807.